|
|
Article: Research and Markets: Lack of compliance with good clinical practice in sponsoring or performing clinical studies will result in regulatory sanctions and refusal of approvals.
- Article from:
- M2 Presswire
- Article date:
- November 11, 2004
CopyrightCOPYRIGHT 2004 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-11 November 2004-Research and Markets: Research and Markets: Lack of compliance with good clinical practice in sponsoring or performing clinical studies will result in regulatory sanctions and refusal of approvals.(C)1994-2004 M2 COMMUNICATIONS LTD
RDATE:11222004
Research and Markets (http://www.researchandmarkets.com/reports/c9156) has announced the addition of A Guide to Good Clinical Practice to their offering
This Guide contains the most recent versions of the regulations issued by the USA, Canada, the European Union, Japan, and the Consolidated Guidelines of the International Conference of Harmonization. Lack of compliance ...